5-Iodotubercidin and proglycosyn: A comparison of two glycogenic compounds in hepatocytes from fasted rats

被引:5
作者
FluckigerIsler, R
Kux, E
Walter, P
机构
[1] Department of Biochemistry, Vesalianum, CH-4051 Basel
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1996年 / 1311卷 / 02期
关键词
glycogen synthesis; glycolysis; fructose-2,6-bisphosphate; (rat hepatocyte); SUBSTRATE CYCLE; STIMULATION; ADENOSINE; LIVER;
D O I
10.1016/0167-4889(95)00196-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-Iodotubercidin (Itu) and proglycosyn (Pro) have similar glycogenic properties. To compare their mechanisms of action, we tested them in hepatocytes from fasted rats. We show that both compounds are similar in that they stimulated glycogen synthesis, increased the concentration of synthase a, decreased that of phosphorylase a and lowered the concentration of F-2,6-P-2 in the presence of glucose, lactate-pyruvate and amino acids. However, when amino acids were absent, Pro was the better stimulator of glycogenesis than Itu and in combination they elevated glycogen and synthase a concentrations synergistically. Further they differ in that (1) Itu enhanced the levels of cyclic AMP whereas Pro did not; (2) Pro depressed glucose production from gluconeogenic substrates, whereas Itu stimulated this process; (3) the inhibition of F-2,6-P-2 formation and glycolysis by Pro became much weaker than that by Itu when glucose concentrations were raised from 10 to 20 mM. Inhibition of glycolysis but not that of glycogen synthesis was partly due to a phosphorylated metabolite of Itu. The present study indicates that despite their similar glycogenic effects, Itu and Pro do not share a common mechanism of action. Further, the inhibition of glycolysis and F-2,6-P-2 formation by Itu cannot be explained if it acts solely as a general inhibitor of protein kinases.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 29 条
[1]  
BAQUET A, 1990, J BIOL CHEM, V265, P955
[2]   EVIDENCE FOR A SUBSTRATE CYCLE BETWEEN AMP AND ADENOSINE IN ISOLATED HEPATOCYTES [J].
BONTEMPS, F ;
VANDENBERGHE, G ;
HERS, HG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (10) :2829-2833
[3]  
CHEN RF, 1967, J BIOL CHEM, V242, P173
[4]  
CHEUNG WY, 1970, ROLE CYCLIC AMP CELL, P52
[5]   INHIBITION OF PURINE BIOSYNTHESIS DE-NOVO IN SARCOMA 180 ASCITES-CELLS BY MERCAPTO AND SELENO PURINE ANALOGS [J].
CRABTREE, GW ;
SCHOLAR, EM ;
CHU, SH ;
PARKS, RE .
BIOCHEMICAL PHARMACOLOGY, 1973, 22 (02) :155-162
[6]   STUDIES ON SEVERAL PYRROLO[2,3-D]PYRIMIDINE ANALOGS OF ADENOSINE WHICH LACK SIGNIFICANT AGONIST ACTIVITY AT A1 AND A2 RECEPTORS BUT HAVE POTENT PHARMACOLOGICAL ACTIVITY INVIVO [J].
DAVIES, LP ;
BAIRDLAMBERT, J ;
MARWOOD, JF .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (18) :3021-3029
[7]   GLYCOGEN-SYNTHASE PHOSPHATASE-ACTIVITY IN RAT-LIVER - 2 PROTEIN-COMPONENTS AND THEIR REQUIREMENT FOR THE ACTIVATION OF DIFFERENT TYPES OF SUBSTRATE [J].
DOPERE, F ;
VANSTAPEL, F ;
STALMANS, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1980, 104 (01) :137-146
[8]  
FLUCKIGERISLER RE, 1993, BIOCHEM J, V292, P85
[9]  
GUO ZK, 1991, J BIOL CHEM, V266, P22323
[10]  
GUTMANN I, 1974, METHODEN ENZYMATISCH, P1511